Please assess the completion status of the following clinical trial:

Trial Title: A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Recipient of a first-time kidney transplant~* Between the ages of 18 and 70 years, inclusive~Exclusion Criteria:~* Recipient of any non-kidney transplant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- CP-690,550 15 mg BID (Type: EXPERIMENTAL): None
- CP-690,550 30 mg BID (Type: EXPERIMENTAL): None
- tacrolimus (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).